Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
- 1 April 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9316) , 1471-1477
- https://doi.org/10.1016/s0140-6736(02)08434-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Factors influencing the effect of age on prognosis in breast cancer: population based study Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancerBMJ, 2000
- BRCA1 and BRCA2: from molecular genetics to clinical medicine.Journal of Clinical Oncology, 1998
- BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast CancerNew England Journal of Medicine, 1997
- Breast carcinomas occurring in young women (< 35 years) are differentBritish Journal of Cancer, 1996
- Germline BRCA1 185delAG mutations in Jewish women with breast cancerThe Lancet, 1996
- Germ-LineBRCA1Mutations in Jewish and Non-Jewish Women with Early-Onset Breast CancerNew England Journal of Medicine, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- Age as prognostic factor in premenopausal breast carcinomaThe Lancet, 1993
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990